169 related articles for article (PubMed ID: 18204351)
1. Suicidal ideation associated with duloxetine use: a case series.
Parikh AR; Thatcher BT; Tamano EA; Liskow BI
J Clin Psychopharmacol; 2008 Feb; 28(1):101-2. PubMed ID: 18204351
[No Abstract] [Full Text] [Related]
2. Manic switching in patients receiving duloxetine.
de Dios C; Ezquiaga E
Am J Psychiatry; 2007 Jul; 164(7):1121. PubMed ID: 17606669
[No Abstract] [Full Text] [Related]
3. Digging for data on harms in duloxetine trials.
Doshi P; Zito J; dosReis S
BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
[No Abstract] [Full Text] [Related]
4. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
Lee SI; Keltner NL
Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
[No Abstract] [Full Text] [Related]
5. Hypogonadism and gynecomastia with duloxetine.
Weydt P; Schönfeldt-Lecuona CJ; Gahr M; Connemann BJ
Pharmacopsychiatry; 2011 Mar; 44(2):77. PubMed ID: 21298612
[No Abstract] [Full Text] [Related]
6. Burning paresthesia related to duloxetine therapy.
Woo YS; Bahk WM
J Clin Psychopharmacol; 2014 Jun; 34(3):392-4. PubMed ID: 24633002
[No Abstract] [Full Text] [Related]
7. Duloxetine-induced cutaneous adverse reaction.
Oulis P; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kouzoupis AV; Soldatos CR
J Clin Psychopharmacol; 2008 Feb; 28(1):104-5. PubMed ID: 18204353
[No Abstract] [Full Text] [Related]
8. Duloxetine--three birds with one stone?
Michel MC
Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
[No Abstract] [Full Text] [Related]
9. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
Emslie GJ; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
J Child Adolesc Psychopharmacol; 2014 May; 24(4):170-9. PubMed ID: 24815533
[TBL] [Abstract][Full Text] [Related]
10. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
Atkinson SD; Prakash A; Zhang Q; Pangallo BA; Bangs ME; Emslie GJ; March JS
J Child Adolesc Psychopharmacol; 2014 May; 24(4):180-9. PubMed ID: 24813026
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder.
Acharya N; Rosen AS; Polzer JP; D'Souza DN; Perahia DG; Cavazzoni PA; Baldessarini RJ
J Clin Psychopharmacol; 2006 Dec; 26(6):587-94. PubMed ID: 17110815
[TBL] [Abstract][Full Text] [Related]
12. Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function.
Ravindran LN; Eisfeld BS; Kennedy SH
J Clin Psychopharmacol; 2008 Feb; 28(1):107-8. PubMed ID: 18204355
[No Abstract] [Full Text] [Related]
13. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
[TBL] [Abstract][Full Text] [Related]
14. Serotonin syndrome induced by duloxetine.
Hadikusumo B; Ng B
Aust N Z J Psychiatry; 2009 Jun; 43(6):581-2. PubMed ID: 19452666
[No Abstract] [Full Text] [Related]
15. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
Hsiao MC; Liu CY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
[No Abstract] [Full Text] [Related]
16. Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study.
Maund E; Tendal B; Hróbjartsson A; Lundh A; Gøtzsche PC
BMJ; 2014 Jun; 348():g3555. PubMed ID: 24899651
[TBL] [Abstract][Full Text] [Related]
17. Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report.
Himmighoffen H; Seifritz E; Boeker H
Pharmacopsychiatry; 2011 Mar; 44(2):75-6. PubMed ID: 21161885
[No Abstract] [Full Text] [Related]
18. Immediate switching from moclobemide to duloxetine may induce serotonin syndrome.
Jimenez-Genchi A
J Clin Psychiatry; 2006 Nov; 67(11):1821-2. PubMed ID: 17196070
[No Abstract] [Full Text] [Related]
19. Efficacy, tolerability, and safety of duloxetine.
Wise TN
CNS Spectr; 2005 Dec; 10(12 Suppl 19):10-1. PubMed ID: 18841598
[No Abstract] [Full Text] [Related]
20. Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studies.
Oakes TM; Katona C; Liu P; Robinson M; Raskin J; Greist JH
Int Clin Psychopharmacol; 2013 Jan; 28(1):1-11. PubMed ID: 23138680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
